Market Research Logo

Blood Collection, Processing, Management Devices & Consumables Global Market - Forecast To 2023

Blood Collection, Processing, Management Devices & Consumables Global Market - Forecast To 2023

Blood collection, processing, management devices & consumables are class of medical devices used for collecting the whole blood from the donor, segregating the collected blood into blood components like RBC, WBC, platelets & plasma and then preserving the segregated components for the purpose of therapeutics and maintaining the protocols of available blood groups and donor information for serving the emergency purposes. These devices are mainly used for therapeutic and diagnostic medical applicational areas, where in therapeutic application the processed blood act as a lifesaving liquid organ. These blood collection, processing, management devices & consumables help in avoiding the transmission of infectious diseases and other complications during transfusion.

Blood collection, processing, management devices & consumables market is segmented on the basis of applications, products, end-users and geography. In blood collection, processing, management devices & consumables market, applications market is further classified into diagnostics, therapeutics, research and others (transplantation compatibility tests and therapeutic drug effect monitoring), whereas diagnostics application market is further sub classified into infectious disease diagnosis, non infectious disease diagnosis, blood typing and others (doping, forensics and pregnancy tests), therapeutic applications are further segmented into hematology diseases, injury, trauma & surgeries and oncology. Products market is segmented into by devices, consumables, softwares and servicing, whereas devices are further classified into hematocrit centrifuges, blood grouping analyzers, blood coagulation analyzers, hematology analyzers, blood processors, blood warmers, blood bank refrigerators, blood bank freezers, slide stainer others. Consumables are subsegmented into blood administration sets, blood collection needles & syringes, blood collection tubes & microcollectors, blood lancets, blood filters, hematology reagents, blood bags, microscopic slides, vials, sedimentation tubes, blood grouping reagents, blood coagulation reagents, blood bags, blood filters, sedimentation tubes, hematology reagents, vials and others. By softwares are further segmented into hospital softwares and blood bank softwares. End-users are further classified into hospitals, diagnostic laboratories, academic & research laboratories, blood & blood component banks, ambulatory surgical center and others (biopharma & biotech companies and clinics).

Among the blood collection, processing, management devices & consumables product market, consumables segment holds the largest share and is expected to be the fastest growing segment from 2016 to 2023. In end-users, Hospitals are the largest segment and is the fastest growing segment from 2016 to 2023. Geographically, North America is the largest market followed by Europe and Asia Pacific. The APAC region is the fastest growing region from 2016 to 2023 presenting an array of opportunities for growth and is likely to get attention of new investors in the blood collection, processing, management devices & consumables market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.

The blood collection, processing, management devices & consumables market is expected to grow at a mid range single digit CAGR to reach $35,693 million by 2023. Increase in aging population and subsequent rise in incidence of chronic diseases, emergence of advanced automated blood collection and processing devices and favourable reimbursement policies are the factors driving the market growth. Emergence of needle free devices & RFID technology and market expansion opportunities in emerging countries are some of the opportunities of this market.

However various factors like patient safety risks due to chances of transmission of infectious diseases and lack of skilled professionals in handling automated processing devices limit the growth of blood collection, processing, management devices & consumables global market. The threats for the blood collection, processing, management devices & consumables market include soaring costs of blood handling devices and stringent government regulatory bodies guiding blood processing devices & consumables manufacturers.

The blood collection, processing, management devices & consumables global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the Blood collection, processing, management devices & consumables market are Abbott Laboratories (U.S.), Becton Dickinson & Company (U.S.), Haemonetics Corporation (U.S.), Grifols International S.A. (Spain), Immucor, Inc. (U.S.), Danaher Corporation (U.S.), Fresenius Kabi (U.K.), Sysmex Corporation (Japan), Terumo Corporation (Japan), Macopharma (France), ThermoFisher Scientific Corporation (U.S.).

The report provides an in depth market analysis of the above mentioned segments across the following regions and their sub regions:

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)


1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKE AWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increase in aging population and subsequent rise in incidence of
chronic diseases
3.3.1.2 Emergence of advanced automated blood collection & processing devices
3.3.1.3 Favorable reimbursement policies
3.3.1.4 Emergence of needle free devices and RFID technology
3.3.1.5 Market expansion opportunities in emerging nations
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Patient safety risks due to chances of transmission of infections and infectious diseases
3.3.2.2 Lack of skilled professionals in handling automated processing devices
3.3.2.3 Soaring cost of blood processing devices
3.3.2.4 Stringent regulatory bodies guiding the blood collection, processing,
management devices & consumables manufacturers
3.4 REGULATORY AFFAIRS
3.4.1 U.S.
3.4.2 EUROPE
3.4.3 INDIA
3.4.4 CHINA
3.4.5 JAPAN
3.5 REIMBURSEMENT SCENARIO
3.5.1 REIMBURSEMENT TABLE
3.6 TECHNOLOGICAL ADVANCEMENTS
3.6.1 AUTOMATED BLOOD COLLECTION & PROCESSING DEVICES
3.6.2 PORTABLE BLOOD COLLECTION & PROCESSING DEVICES
3.6.3 CUSTOMIZED BLOOD COLLECTION, PROCESSING DEVICES & CONSUMABLES
3.6.4 HEMOSEP 3-D PRINTED BLOOD COLLECTION DEVICES
3.6.5 MICROFLUIDIC BLOOD COLLECTION DEVICES
3.6.6 RFID (RADIOFREQUENCY IDENTIFICATION) TECHNOLOGY
3.6.7 ROBOTICS IN BLOOD COLLECTION & MANAGEMENT
3.7 MANUAL V/S AUTOMATED BLOOD COLLECTION AND PROCESSING DEVICES
3.8 SUPPLY CHAIN ANALYSIS
3.9 PORTER’S FIVE FORCE ANALYSIS
3.9.1 THREAT OF NEW ENTRANTS
3.9.2 THREAT OF SUBSTITUTES
3.9.3 RIVALRY AMONG EXISTING COMPETITORS
3.9.4 BARGAINING POWER OF SUPPLIERS
3.9.5 BARGAINING POWER OF BUYERS
3.10 MARKET SHARE ANALYSIS
4 BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET, BY PRODUCTS
4.1 INTRODUCTION
4.2 BY DEVICES
4.2.1 HEMATOCRIT CENTRIFUGE
4.2.2 BLOOD GROUPING ANALYZERS
4.2.3 BLOOD COAGULATION ANALYZERS
4.2.4 HEMATOLOGY ANALYZERS
4.2.5 BLOOD CELL PROCESSORS
4.2.6 BLOOD WARMERS
4.2.7 BLOOD BANK REFRIGERATORS
4.2.8 BLOOD BANK FREEZERS
4.2.9 SLIDE STAINERS
4.2.10 OTHERS
4.3 CONSUMABLES
4.3.1 BLOOD COLLECTION NEEDLE & SYRINGE
4.3.2 BLOOD COLLECTION TUBES & MICROCOLLECTORS
4.3.3 BLOOD LANCETS
4.3.4 BLOOD BAGS
4.3.5 BLOOD FILTERS
4.3.6 SEDIMENTATION TUBES
4.3.7 BLOOD COAGULATION REAGENTS
4.3.8 BLOOD GROUPING REAGENTS
4.3.9 HEMATOLOGY REAGENTS
4.3.10 BLOOD ADMINISTRATION SETS
4.3.11 BLOOD VIALS
4.3.12 OTHERS
4.4 MANAGEMENT SOFTWARES
4.4.1 BLOOD BANK SOFTWARES
4.4.2 HOSPITAL SOFTWARES
4.5 SERVICING
5 BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET, BY APPLICATION
5.1 INTRODUCTION
5.2 DIAGNOSTICS
5.2.1 INFECTIOUS DISEASE DIAGNOSIS
5.2.2 NON-INFECTIOUS DISEASE DIAGNOSIS
5.2.3 BLOOD TYPING
5.2.4 OTHERS
5.3 THERAPEUTICS
5.3.1 HAEMATOLOGY DISEASES
5.3.2 INJURY, TRAUMA & SURGERY
5.3.3 ONCOLOGY
5.4 RESEARCH
5.5 OTHERS
6 BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET, BY END-USERS
6.1 INTRODUCTION
6.2 HOSPITALS
6.3 ACADEMIC INSTITUTES & RESEARCH LABORATORIES
6.4 DIAGNOSTIC LABORATORIES
6.5 AMBULATORY SURGICAL CENTERS
6.6 BLOOD & BLOOD COMPONENT BANK
6.7 OTHERS
7 REGIONAL MARKET ANALYSIS
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 OTHERS
7.3 EUROPE
7.3.1 GERMANY
7.3.2 FRANCE
7.3.3 ITALY
7.3.4 OTHERS
7.4 ASIA PACIFIC
7.4.1 INDIA
7.4.2 CHINA
7.4.3 JAPAN
7.4.4 OTHERS
7.5 REST OF THE WORLD (ROW)
7.5.1 BRAZIL
7.5.2 MIDDLE EAST
7.5.3 OTHERS
8 COMPANY DEVELOPMENTS
8.1 INTRODUCTION
8.1.1 APPROVAL AS A MAJOR GROWTH STRATEGY OF BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES PLAYERS
8.2 APPROVALS
8.3 NEW PRODUCT LAUNCH
8.4 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES
8.5 OTHER DEVELOPMENTS
8.6 MERGERS & ACQUISITIONS
9 COMPANY PROFILES
9.1 ABBOTT LABORATORIES, INC
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCT PORTFOLIO
9.1.4 KEY DEVELOPMENTS
9.1.5 BUSINESS STRATEGY
9.1.6 SWOT ANALYSIS
9.2 BIO-RAD LABORATORIES
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCT PORTFOLIO
9.2.4 KEY DEVELOPMENTS
9.2.5 BUSINESS STRATEGY
9.2.6 SWOT ANALYSIS
9.3 BIOMERIEUX
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCT PORTFOLIO
9.3.4 KEY DEVELOPMENTS
9.3.5 BUSINESS STRATEGY
9.3.6 SWOT ANALYSIS
9.4 BECTON DICKINSON AND COMPANY
9.4.1 OVERVIEW
9.4.2 FINANCIALS
9.4.3 PRODUCT PORTFOLIO
9.4.4 KEY DEVELOPMENTS
9.4.5 BUSINESS STRATEGY
9.4.6 SWOT ANALYSIS
9.5 DANAHER CORPORATION (BECKMAN COULTER)
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCT PORTFOLIO
9.5.4 KEY DEVELOPMENTS
9.5.5 BUSINESS STRATEGY.
9.5.6 SWOT ANALYSIS
9.6 FRESENIUS KABI
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCT PORTFOLIO
9.6.4 KEY DEVELOPMENTS
9.6.5 BUSINESS STRATEGY
9.6.6 SWOT ANALYSIS
9.7 GRIFOLS INTERNATIONAL SA
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCT PORTFOLIO
9.7.4 KEY DEVELOPMENTS
9.7.5 BUSINESS STRATEGY
9.7.6 SWOT ANALYSIS
9.8 HAEMONETICS CORPORATION
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCT PORTFOLIO
9.8.4 KEY DEVELOPMENTS
9.8.5 BUSINESS STRATEGY
9.8.6 SWOT ANALYSIS
9.9 IMMUCOR INC
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCT PORTFOLIO
9.9.4 KEY DEVELOPMENTS
9.9.5 BUSINESS STRATEGY
9.9.6 SWOT ANALYSIS
9.10 MACOPHARMA
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCT PORTFOLIO
9.10.4 KEY DEVELOPMENTS
9.10.5 BUSINESS STRATEGY
9.10.6 SWOT ANALYSIS
9.11 ROCHE DIAGNOSTICS
9.11.1 OVERVIEW
9.11.2 FINANCIALS
9.11.3 PRODUCT PORTFOLIO
9.11.4 KEY DEVELOPMENTS
9.11.5 BUSINESS STRATEGY
9.11.6 SWOT ANALYSIS
9.12 SYSMEX CORPORATION
9.12.1 OVERVIEW
9.12.2 FINANCIALS
9.12.3 PRODUCT PORTFOLIO
9.12.4 KEY DEVELOPMENTS
9.12.5 BUSINESS STRATEGY
9.12.6 SWOT ANALYSIS
9.13 TERUMO CORPORATION
9.13.1 OVERVIEW
9.13.2 FINANCIALS
9.13.3 PRODUCT PORTFOLIO
9.13.4 KEY DEVELOPMENTS
9.13.5 BUSINESS STRATEGY
9.13.6 SWOT ANALYSIS
9.14 THERMO FISHER SCIENTIFIC, INC
9.14.1 OVERVIEW
9.14.2 FINANCIALS
9.14.3 PRODUCT PORTFOLIO
9.14.4 KEY DEVELOPMENTS
9.14.5 BUSINESS STRATEGY
9.14.6 SWOT ANALYSIS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report